Invent it, swap it or buy it

Bain & Company partner, Nils Behnke is quoted by The Economist on findings from Bain's M&A pharma research. Behnke explains, "over the period covered by its study, the best-performing drug companies got more than 70% of their revenues from products that were not developed in-house."